Show simple item record

Frontiers in New Drug Discovery

From Molecular Targets to Preclinical Trials

dc.contributor.editorAminin, Dmitry
dc.date.accessioned2023-06-23T09:47:03Z
dc.date.available2023-06-23T09:47:03Z
dc.date.issued2023
dc.identifierONIX_20230623_9783036576831_73
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/100841
dc.description.abstractThe intention of this Special Issue is to focus on new aspects of drug discovery, including the search for new molecular targets of various diseases, the creation of new modern methods for diagnosing diseases, the development of new test systems and kits for assessing the selectivity and effectiveness of new drugs, the study of the molecular mechanisms of biologically active compounds, the formulation of new drugs, pharmacokinetic and pharmacodynamic studies, and preclinical trials of important molecules.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.otherStreptococci
dc.subject.otherantimicrobials
dc.subject.otherQSAR
dc.subject.otherMD simulation
dc.subject.otherKunitz-type peptides
dc.subject.otherneuroprotective activity
dc.subject.othersea anemones
dc.subject.otherTRPV1
dc.subject.otherP2X7R
dc.subject.otherParkinson’s disease (PD)
dc.subject.otherdiffuse large B cell lymphoma (DLBCL)
dc.subject.otherdeep neural network
dc.subject.otherdrug discovery
dc.subject.otherdrug combination
dc.subject.otherbiomarker
dc.subject.othercancer severity
dc.subject.othercancer prognosis
dc.subject.otherMAFB
dc.subject.othertumor-associated macrophages
dc.subject.otherprostate cancer
dc.subject.otherphotodynamic therapy
dc.subject.othermagnetic resonance imaging
dc.subject.otherex vivo
dc.subject.otheranti-inflammatory substance
dc.subject.otherN-acylhydrazone
dc.subject.othernaphthyl-N-acylhydrazone
dc.subject.otherLASSBio-1524 analogues
dc.subject.otherphosphacoumarin
dc.subject.otherazomethine ylide
dc.subject.othercycloaddition
dc.subject.otheranti-cancer
dc.subject.othercytotoxicity
dc.subject.otherquantum chemistry
dc.subject.otherpravastatin
dc.subject.othermetformin
dc.subject.otherradiation-induced intestinal injury
dc.subject.otherminipigs
dc.subject.otherepithelial regeneration
dc.subject.otherinflammation
dc.subject.otherarylazo sulfones
dc.subject.otherDNA binding
dc.subject.otherDNA cleavage
dc.subject.otherDNA photocleavage
dc.subject.otherA375 melanoma cells
dc.subject.othermolecular docking
dc.subject.otherradicals
dc.subject.otherN–S bond homolysis
dc.subject.otherplatinum(II)
dc.subject.otherfive-coordinate complexes
dc.subject.otherglycoconjugation
dc.subject.othercytotoxic activity
dc.subject.otherprotein X-ray structure
dc.subject.otherlipophilicity
dc.subject.othernatural products
dc.subject.otheracetylcholinesterase inhibitors
dc.subject.otherbutyrylcholinesterase inhibitors
dc.subject.otherAlzheimer’s disease
dc.subject.othercentral nervous system
dc.subject.othern/a
dc.titleFrontiers in New Drug Discovery
dc.title.alternativeFrom Molecular Targets to Preclinical Trials
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-7682-4
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036576831
oapen.relation.isbn9783036576824
oapen.pages236
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/